Projecting potential market share for newly approved Relistor; monitoring exec moves at Introgen; and more.
9:26AM 04/30/08
Vertex's cystic fibrosis compound shows promise, but be cautious in your enthusiasm. Also, an update on the quest for blood substitutes.
12:01PM 03/29/08
Flotek sinks.
4:01PM 11/01/07
It's hard to believe the blood-substitute maker didn't know of the heart attack risks earlier.
12:04AM 08/07/07
The company's confidence in approval for its blood substitute disregards its own data.
12:10AM 06/20/07
Data discrepancies will mean a reanalysis of a clinical trial. The stock sinks 55%.
5:59PM 12/19/06
As the Dow hits a new high, money manager Ken Fisher explains why stocks will keep rallying in '07.
5:42PM 12/15/06
Genta plunges as regulators say its cancer treatment is not approvable.
1:55PM 12/15/06
Shares fall 29%.
12:55PM 12/15/06
Inspire Pharmaceuticals' dry-eye treatment fails to inspire FDA approval.
3:04PM 12/02/05
Our Experts' Take at RealMoney
However, option traders boost January calls.
4:37PM 11/21/08
This market is producing a few stocks that could represent exceptional opportunities.
3:03PM 11/21/08
More Experts' Takes
More popular tickers are indicated by scale.



